<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00485784</url>
  </required_header>
  <id_info>
    <org_study_id>2006/26</org_study_id>
    <nct_id>NCT00485784</nct_id>
  </id_info>
  <brief_title>Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications</brief_title>
  <official_title>Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <brief_summary>
    <textblock>
      This is a prospective multicentric study including four clinical units of Gynecology and
      Obstetrics (3 public health hospitals and one private team), one research team in Hematology
      and one Center of Clinical investigation (CIC).

      The objective is to identify, beside the pregnancy, in a population of patients with a
      preeclampsia (PE), with fetus presenting with growth restriction (IUGR) and a fetal demise
      (FD) a modification of circulating endothelial biomarkers compared with normal pregnancy.

      We want to understand better the physiopathology of preeclampsia and propose to patients with
      an endothelial dysfunction a early prevention of preeclampsia.

      Patients will be tested 3 times : At the pregnancy events; then 8 weeks and 12 months after
      the birth.

      Four groups will be constituted among patients: PE, IUGR, FD and normal pregnancy.

      Normal pregnancy will be tested as controls. The next pregnancy presenting in the unit to
      medical pregnancy follow up will be invited to participate.

      The main judgment criteria will be the levels of endothelial microparticles 8 weeks after the
      event.

      The study will last 3 years. The number of patient to include is 280.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bring to light except the pregnancy within a population of presenting patients one EP, a RCIU and a MFIU a modification of biomarkers circulating endothéliaux with regard to the normal pregnancy.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prééclampsies group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prééclampsies group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RCIU group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RCIU group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MFIU group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MFIU group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>Blood test</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>prééclampsies group</arm_group_label>
    <arm_group_label>RCIU group</arm_group_label>
    <arm_group_label>MFIU group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant patients aged more than 18 years and more than 12 weeks of gestation for FD
             group, 20 weeks of gestation for PE or IUGR group , presenting either:

          -  PE (arterial pressure more than 140 mm Hg and 90 mm Hg) and at least a proteinuria
             evaluated on stick (one point) or 300 mg/24h.

          -  IUGR with biometries below 5° percentile according to the graphs of fetal echography
             college after 20 weeks of gestation.

          -  FD after 12 weeks of gestation or with a cranio-caudal length of more than 45 mm.

          -  Normal pregnancy adjusted for gestational age and parity : Patient should have no
             cardio-vascular past with a normal complication at the inclusion time and from which
             pregnancy remains uneventful until the term. The onset of premature delivery,
             hypertension or fetal growth restriction will exclude patients from the control group.

          -  social security cover

          -  written informed consent

        Exclusion Criteria:

          -  Foetal malformation

          -  APLS known

          -  Set back of patient consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence BRETELLE, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unité Mère-Enfant Hôpital Nord 13005 Marseille - Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Saint-Joseph - Service de Gynécologie-Obstétrique</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Nice Hopital de L'Archet</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2007</study_first_submitted>
  <study_first_submitted_qc>June 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2007</study_first_posted>
  <last_update_submitted>August 27, 2014</last_update_submitted>
  <last_update_submitted_qc>August 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

